Damian McNamara
News
IDSA updates COVID guidelines for antibodies, antivirals, other drugs
November 24, 2020
Panel cautions against routine use of bamlanivimab and notes that remdesivir can shorten the clinical course of COVID-19.
News
Pfizer’s COVID-19 vaccine 95% effective in final phase 3 results
November 19, 2020
The vaccine was well tolerated with no serious safety concerns.
Article
Moderna: Interim data show 94.5% efficacy for COVID-19 vaccine, will seek FDA EUA
November 16, 2020
The first interim results of the phase 3 COVE trial included 95 participants with confirmed COVID-19.
News
Moral distress: COVID-19 shortages prompt tough decisions at bedside
November 11, 2020
Many hospital crisis capacity plans were too general to address all the specific challenges arising during the pandemic.
![1]()
News
FDA grants emergency use authorization to Lilly’s antibody COVID-19 therapy
November 10, 2020
“We have supplies to distribute now. Product distribution will begin this week.”
![1]()
News
Higher cardiovascular risks in Kawasaki disease persist 10-plus years
November 8, 2020
Researchers evaluated the incidence of myocardial infarction, stroke, death, and more in a follow-up study of Kawasaki disease survivors, compared to unaffected children.
![1]()
News
COVID-19 risks in rheumatic disease remain unclear
November 7, 2020
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.
News
Common SARS-CoV-2 mutation may be making COVID-19 more contagious
November 5, 2020
In contrast to a greater variety of strains early in the pandemic, now 99.9% of circulating SARS-CoV-2 strains in the study feature the D614G mutation on the spike protein.
News
About 17% of COVID-19 survivors retest positive in follow-up study
November 2, 2020
The findings could carry important implications for people who continue to be symptomatic.
News
More mask wearing could save 130,000 US lives by end of February
October 29, 2020
“Case numbers are climbing in the US, and without further intervention, there will be a significant number of deaths over the coming months.”
